Scope of the Proposed International Legally Binding Instrument on Transnational Corporations and Other Business Enterprises with respect to Human Rights
The elaboration of an ‘International Legally Binding Instrument on Transnational Corporations and other Business Enterprises with respect to Human Rights’ (hereinafter ‘the Instrument’), as mandated by the Human Rights Council at its 26th Ordinary Session (June 26, 2014), requires definitions about a multiplicity of issues. Many choices need to be made among possible policy options and properly reflected in treaty language. (more…)
The Declaration on the Right to Development, adopted by the UN General Assembly in 1986 (as Document 41/128) is 30 years old. It is appropriate to celebrate this anniversary. For the right to development has had great resonance among people all over the world, including in developing and poor countries. Even the term itself “the right to development” carries a great sense and weight of meaning and of hope. (more…)
Derechos de Propiedad Intelectual, Investigación y Desarrollo, Derechos Humanos y Acceso a Medicamentos: Bibliografía Seleccionada y Anotada
Descripción:
El Centro del Sur ha preparado esta bibliografía seleccionada y anotada para asistir a los países en desarrollo en la implementación de políticas y reglamentaciones en materia de PI de manera coherente con los objetivos de desarrollo y los principios de salud pública. El creciente volumen de literatura que se está produciendo en torno al tema de PI, I+D, derechos humanos y acceso a medicamentos en los últimos cinco años puede ayudar a los países a encontrar las oportunidades y el espacio de maniobra para proteger a los ciudadanos de los países en desarrollo del medio insano que han generado las nuevas normas del comercio internacional.
Autores: Germán Velásquez, Carlos M. Correa, Xavier Seuba
IPR, R&D, Human Rights and Access to Medicines: An Annotated and Selected Bibliography
About the Book: The South Centre seeks to provide the appropriate technical assistance and country support to developing countries, within a comprehensive and coherent national IP Strategy, to promote the implementation of the TRIPS Agreement that is consistent with the protection of public health and promotion of access to medicines. To this end, the South Centre has prepared this selected and annotated bibliography to assist developing countries to implement IP policies and regulations consistent with development goals and public health principles.
Authors: Germán Velásquez, Carlos Correa and Xavier Seuba
The Right to Development, Small Island Developing States and the SAMOA Pathway
In 2015, the United Nations community reached agreements on updating the financing for development mechanisms, Agenda 2030 and an updated climate change regime. The SAMOA pathway is an important resource and an input to these efforts. (more…)
International Investment Agreements and Africa’s Structural Transformation: A Perspective from South Africa
The brief describes the widening debate on the implications of international investment agreements (IIAs) for sustainable development. This debate is particularly relevant in Africa as the continent’s new economic development programme to effect structural transformation and achieve sustainable development may well be constrained by the terms and conditions imposed by IIAs. (more…)
Malala got the Nobel peace prize; here’s why Nabila won’t
By Staff, Firstpost of India
Last week, the Nobel Peace Prize committee announced two winners: Pakistan’s Malala Yousafzai and India’s Kailash Satyarthi for their struggle for the rights of children. While for most Indians K Satyarthi’s name was a bit of a mystery, Malala was already a widely known international figure, her personal story documented on magazine covers around the world. The celebration of Malala in the West has long inspired conspiracy theorists who view her as a CIA stooge — and that she is now the youngest recipient for the Nobel Peace Prize is likely to prove more fodder for the same. But you don’t have to be paranoid to ask the question raised by Murtaza Hussain in Al-Jazeera: What about Nabila Rehman? (more…)
Loss and Damage Mechanism Set Up for Climate Change
The UN Climate Conference held in Warsaw has set up a new international mechanism to help developing countries affected by loss and damage from climate change, such as the Philippines typhoon. (more…)
Integrating a Gender Perspective in Climate Change, Development Policy and the UNFCCC
This policy brief discusses the opportunities, challenges and constraints for integrating a gender perspective into global climate change policy as well as the current effort of gender mainstreaming in the UNFCCC. The brief is a companion piece to a previous note that explored the nature, content and implications of the Gender Decision made at COP 18, Doha, 2012. (more…)
Development-led Globalization Requires De-colonizing the MDGs
By Manuel Montes
The big attraction of the eight Millennium Development Goals (MDGs), or at least the first seven of these, was their near universal acceptability. It mobilized both resources and politics, both nationally and internationally, in pursuit of reducing poverty, hunger, gender inequality, malnutrition and disease.
As the northern Indian state of Rajasthan rolls out an ambitious universal healthcare plan, the discontent of the state’s doctors stands in stark contrast to the joys of the 68 million people who will benefit from the scheme.
A resolution by the World Health Assembly: Will there finally be a cure for diseases that affect the poor?
By Carlos Correa
On 26 May 2012 the World Health Assembly adopted a resolution that could mark the first step toward a change in the current pharmaceutical research model. The members of the World Health Organization (WHO) decided to undertake an in-depth examination, at the governmental level, of a report produced in April 2012 by an international group of experts that recommended the adoption of a binding convention on research and development (R&D) that, if approved and implemented, could generate the medicines needed, particularly in developing countries, to address communicable and non-communicable diseases.
